HPV Vaccination and Test Reduce Cancer Risk by More Than 90%

News   Oct 31, 2017 | Original story from Medical University of Vienna

 
HPV Vaccination and Test Reduce Cancer Risk by More Than 90%

U.S. Air Force photo by Staff Sgt. Benjamin W. Stratton

 
 
 

RELATED ARTICLES

Antibody Drug-Conjugate to Target Treatment-Resistant Childhood Leukemia

News

Researchers have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment.

READ MORE

A Breath Test for Early Diagnosis of Oesophageal and Gastric Cancer

News

In a multi-centre clinical trial of 335 patients, a new breath test can identify oesophageal and gastric cancer from benign diseases with 85 per cent accuracy. Unlike other methods, the test is non-invasive.

READ MORE

Single-injection Polio Vaccine

News

A new nanoparticle vaccine developed by MIT researchers could assist efforts to eradicate polio worldwide. The vaccine, which delivers multiple doses in just one injection, could make it easier to immunize children in remote regions of Pakistan and other countries where the disease is still found.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE